Low methylation/high expression primary glioma cultures were picked for lentiviral gene expression modulation of PRPF19 and TERT. Knockdown of PRPF19 and TERT was validated via quantitative real‐time PCR (Figure S7) and resulted in an enhanced response to temozolomide treatment. This evidence concerns the gene PRPF19 and central nervous system cancer.